CDC16 Polyclonal Antibody

CDC16 Polyclonal Antibody

The CDC16 polyclonal antibody is a highly specific and sensitive immunological reagent designed for the detection and quantification of CDC16 protein in various biological samples. This antibody is produced by immunizing rabbits with a synthetic peptide corresponding to the C-terminal region of human CDC16 protein. The resulting polyclonal antibody exhibits high affinity and specificity towards CDC16 protein, making it an ideal tool for various applications such as Western blotting, immunoprecipitation, and immunohistochemistry.

The CDC16 polyclonal antibody is purified using a combination of protein A and protein G chromatography, ensuring high purity and minimal cross-reactivity with other proteins. This antibody has been extensively validated for its specificity and sensitivity, and has been shown to detect endogenous levels of CDC16 protein in various cell lines and tissues.

The CDC16 protein is a key component of the anaphase-promoting complex/cyclosome (APC/C), which is a large multi-subunit E3 ubiquitin ligase that regulates cell cycle progression and mitotic exit. Dysregulation of CDC16 expression or function has been implicated in various human diseases, including cancer and neurodegenerative disorders. Therefore, the CDC16 polyclonal antibody is a valuable tool for studying the role of CDC16 in these diseases and for developing novel therapeutic strategies.

In summary, the CDC16 polyclonal antibody is a highly specific and sensitive immunological reagent that is ideal for the detection and quantification of CDC16 protein in various biological samples. Its high affinity and specificity make it an essential tool for researchers studying the role of CDC16 in cell cycle regulation and disease pathogenesis.